Christa G.M. Gadellaa-van Hooijdonk

Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases

Fleur Weeber, Marc van de Wetering, Marlous Hoogstraat et al. · Proceedings of the National Academy of Sciences · 2015 · 487 citations · Full text

Medicine, Cancer Biology, Oncology +17

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours

Nienke A. G. Lankheet, Jacqueline S. L. Kloth, Christa G.M. Gadellaa-van Hooijdonk et al. · British Journal of Cancer · 2014 · 103 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment

Dennis Winkel, Gijsbert H. Bol, Anita M. Werensteijn-Honingh et al. · Radiotherapy and Oncology · 2020 · 60 citations · Full text

Medicine, Oncology, Radiation Oncology +17

The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies

G.A. Cirkel, Fleur Weeber, Sander Bins et al. · Annals of Oncology · 2016 · 23 citations · Full text

Medicine, Biomedical Sciences, Biostatistics +15

SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases

Jeroen A. Crouzen, A. Petoukhova, Marike L. D. Broekman et al. · BMC Cancer · 2023 · 15 citations · Full text

Medicine, Neurosurgery, Oncology +14